Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty

ClinicalTrials.gov ID: NCT03182933

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03182933. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 11, 2026, 11:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Impact of Liposomal Bupivacaine Injected for Adductor Canal Block on Recovery Profile and Block Characteristics Following Total Knee Arthroplasty.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study will evaluate the effect of liposomal bupivacaine versus standard bupivacaine on physical therapy measures and pain scores as well as opiate consumption.

Study identification

NCT ID: NCT03182933
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 4
Lead sponsor: University of Wisconsin, Madison; Other
Enrollment: 64 participants

Conditions and interventions

Conditions

Pain

Interventions

Peripheral Nerve Blockade Drug
10 meter walk test on post-operative day 1 Behavioral
In person and over the phone questionnaire Other
Force transduction of quadriceps strength Device

Drug · Behavioral · Other + 1 more

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 30, 2017 (Actual)
Primary completion: Jul 16, 2018 (Actual)
Completion: Jul 16, 2018 (Actual)
Last update posted: Jun 25, 2019

2017 – 2018

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
The American Center	Madison	Wisconsin	53718	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03182933, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 25, 2019 · Synced Nov 11, 2026